Buspirone Totally Explained

Everything about Buspirone totally explained

Buspirone (brand-names Ansial, Ansiced, Anxiron, Axoren, Bespar, BuSpar, Buspimen, Buspinol, Buspisal, Narol, Spitomin, Sorbon) is an anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to diazepam in treating generalized anxiety disorder.
   It shows no potential for addiction compared to other drugs commonly prescribed for anxiety, especially benzodiazepine medications. The development of tolerance hasn't been noticed. Cross-tolerance to benzodiazepines, barbiturates and alcohol doesn't exist. Furthermore, it's non-sedating.
   It is thought to act by interfering with the function of the neurotransmitter serotonin in the brain, particularly by serving as a 5-HT1A presynaptic receptor partial agonist. Additionally, it acts as a mixed agonist/antagonist on postsynaptic dopamine receptors. GABA-mediated effects are lacking. Buspirone may also have indirect effects on other neurotransmitters in the brain.
   The action of a single dose is much longer than the short halflife of 2-3 hours indicates. The bioavailability of buspirone is very low and variable due to extensive first pass metabolism. The drug is quickly resorbed. Taking the drug together with food may increase the bioavailability. The drug is highly (95%) plasma-bound. The active metabolite 1-PP is also a 5-HT1A partial agonist with anxiolytic properties, but weaker so than the mother-drug.
   It is also useful as an augmenting agent, for the treatment of depression, when added to SSRIs.
   The main disadvantage is that 1 to 3 weeks elapse before the anxiolytic activity becomes evident. Often patients have to be initially cotreated with a benzodiazepine for immediate anxiolysis. Generally, buspirone works less well than benzodiazepines. Therefore, benzodiazepines are often the first approach in immediately treating panic attacks and social phobias. It is also particularly difficult to treat patients pretreated with benzodiazepines knowing the immediate effects of these tranquilizers. Bristol-Myers Squibb gained FDA approval for Buspirone in 1986. The drug went generic in 2001.

Indications

Generalized anxiety disorder of mild to moderate intensity (it isn't considered effective against other types of anxiety disorders such as obsessive-compulsive disorder, with or without agoraphobia and social phobia)
Augmention of SSRI-treatment against depression

Contraindications

Myasthenia gravis

Acute closed angle glaucoma

Severely compromised liver- and renal-function

Concomitant treatment with a MAO-Inhibitor (severe hypertensive crises have been seen)

Preexisting heart conditions (for example myocardial infarction)

Side-effects

Rarely, side-effects have a dangerous nature or intensity. Some tend to disappear with continued therapy, or are less frequent if the initial dose is low and increased gradually (vertigo, agitation, insomnia).

Most frequent: vertigo, headaches, nervousness, agitation, light-headedness, nausea;

Often (>1%) : drowsiness, insomnia, concentration disorders, confusion, depression, agitation, intestinal disorders, paresthesia, coordination disorders, tremors, disturbed vision, tinnitus, fatigue, weakness, Angina pectoris, sore throat, tachycardias, palpitations, dry mouth, pain in muscles and joints;

Seldom: allergic reactions, subdermal bleeding, extrapyramidal symptoms, hallucinations, psychosis, ataxia, epileptic seizures, syncope, tunnel vision, urine retention, hyperosmia, alopecia, pruritus, hot flashes. There are no dyscognitive side-effects like those seen in benzodiazepines.
Other side-effects have been seen, but are not more frequent than those encountered with placebo. An unusual side effect reported by patients has been an enhanced sense of smell.

Drug abuse and dependence

Buspirone has no known potential for abuse, psychological or physical dependence.

Interactions

Haloperidol : increased plasma-levels of haloperidol

Rifampicin : decreased plasma-levels of buspirone

MAO-Inhibitors : severe hypertensive crises are possible.

Alcohol : The sedative properties of alcohol are increased slightly.

Grapefruit, Grapefruit juice, Grapefruit extract : drastically increased plasma-levels of Buspirone Do not mix the pills in grapefruit juice.Further Information

Get more info on 'Buspirone'.

External Link Exchanges

Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:

<a href="http://buspirone.totallyexplained.com">Buspirone Totally Explained</a>

Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned.